Form 4: Performant Healthcare Director Sells Over 180,000 Shares Under Pre-Arranged Plan

Lisa Im, a Director at Performant Healthcare Inc., has reported the sale of 180,867 shares of common stock for approximately $587,818, executed under a Rule 10b5-1 trading plan.

Summary

• Lisa Im, a Director of Performant Healthcare Inc. (PHLT), reported the sale of 180,867 shares of the company's common stock.
• The transaction occurred on June 3, 2025, with shares sold at a price of $3.25 per share.
• The total value of the shares sold amounts to approximately $587,817.75.
• Following this transaction, Ms. Im beneficially owns 1,229,413 shares of Performant Healthcare Inc. common stock.
• The sale was conducted pursuant to a Rule 10b5-1 pre-arranged trading plan, indicating it was scheduled in advance.

Sentiment

Score: 5

Explanation: While an insider sale can be perceived negatively, the disclosure that it was executed under a Rule 10b5-1 plan mitigates concerns that it's based on new, negative information. It's a neutral to slightly negative event, often for personal financial planning.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, which suggests the sale was pre-scheduled and not based on immediate, non-public information.

Negatives

• An insider sale, particularly by a director, can sometimes be perceived negatively by investors as it might suggest a lack of confidence in the company's near-term prospects, although the 10b5-1 plan mitigates this to some extent.
• The sale represents a reduction in direct beneficial ownership by a key board member.

Risks

• Potential negative investor sentiment if the market misinterprets the insider sale as a lack of confidence, despite the 10b5-1 plan.
• Increased scrutiny on future company performance following a significant insider transaction.

Future Outlook

This Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This specific filing pertains to an individual insider transaction and does not provide broader industry context or trends. It reflects a personal financial decision by a director rather than a company-wide strategic move.

Stakeholder Impact

• Shareholders: May react to the insider sale, potentially influencing short-term stock price movements, though the 10b5-1 plan may temper negative interpretations.

Next Steps

• This Form 4 filing reports a completed transaction and does not outline future actions, events, or milestones for the company.

Key Dates

Recommendation

Keywords

Performant Healthcare Inc., PHLT, SEC Form 4, Insider Trading, Stock Sale, Director, Lisa Im, Rule 10b5-1, Beneficial Ownership